Tilray Brands (NASDAQ:TLRY) Trading Down 5.1% Following Weak Earnings

Tilray Brands, Inc. (NASDAQ:TLRY)’s stock price traded down 5.1% during mid-day trading on Wednesday after the company announced weaker than expected quarterly earnings. The company traded as low as $6.06 and last traded at $6.14. 5,561,215 shares traded hands during mid-day trading, an increase of 52% from the average session volume of 3,666,924 shares. The stock had previously closed at $6.47.

The company reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.10). Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. The firm had revenue of $206.73 million during the quarter, compared to analyst estimates of $201.35 million. During the same quarter in the previous year, the business earned ($0.87) EPS.

Key Stories Impacting Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Roth/MKM upgraded TLRY from Neutral to Buy, citing the Q3 results as a rebound and assigning a $10 price target — a near-term catalyst that supports buying interest. Roth upgrade
• Positive Sentiment: Jefferies reiterated a Buy and kept a $24 price target, pointing to strong cannabis sales and improving fundamentals — a high-profile vote of confidence that can boost investor conviction. Jefferies reiteration
• Positive Sentiment: Product innovation in beverages: Shock Top (Tilray Beverages) launched “High Voltage,” a 9.6% ABV double wheat beer — demonstrates revenue diversification and new retail skus that could lift beverage sales over time. Shock Top product launch
• Neutral Sentiment: Sector/regulatory tailwind: reports that the FDA will not enforce some CBD regulations have lifted cannabis names broadly, supporting TLRY alongside peers. This is a positive industry backdrop but not a company-specific guarantee. FDA CBD enforcement story
• Neutral Sentiment: Q3 reported record revenue of ~$207M (up ~11% y/y) and Tilray reaffirmed its outlook — revenue growth and a clearer medium‑term story underpin positive sentiment, but investors are parsing the quality of that growth. Q3 highlights / record revenue
• Negative Sentiment: EPS miss: TLRY reported Q3 EPS of ($0.24) vs. ($0.14) expected — the earnings miss and continued negative net margin raise near-term profitability concerns and explain some intraday weakness. Earnings call transcript
• Negative Sentiment: Analyst price target cut: ATB Cormark trimmed its target to $9 and moved to Sector Perform — a more cautious analyst view that can cap upside until margins and execution improve. ATB Cormark price target cut
• Negative Sentiment: Beverage segment weakness and margin pressure were flagged by analysts and some coverage, which helps explain why the stock earlier sold off even with record revenue — execution in beverages and margin recovery remain key risks. Sell-off despite record revenue

Wall Street Analysts Forecast Growth

Several brokerages have commented on TLRY. Wall Street Zen upgraded shares of Tilray Brands from a “sell” rating to a “hold” rating in a research report on Saturday, March 21st. Canaccord Genuity Group assumed coverage on shares of Tilray Brands in a research report on Tuesday, January 27th. They set a “hold” rating on the stock. ATB Cormark Capital Markets reduced their price target on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating for the company in a research report on Thursday. Roth Mkm upgraded Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price target on the stock in a report on Thursday. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tilray Brands in a report on Wednesday, January 21st. Three analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $11.20.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Hilton Head Capital Partners LLC purchased a new stake in shares of Tilray Brands in the fourth quarter valued at $38,000. Engineers Gate Manager LP acquired a new stake in Tilray Brands in the 4th quarter worth about $126,000. Oppenheimer & Co. Inc. acquired a new position in shares of Tilray Brands during the 3rd quarter valued at about $25,000. Silverlake Wealth Management LLC purchased a new position in shares of Tilray Brands during the 3rd quarter worth about $25,000. Finally, Unified Investment Management acquired a new stake in shares of Tilray Brands in the third quarter worth approximately $26,000. 9.35% of the stock is currently owned by institutional investors and hedge funds.

Tilray Brands Price Performance

The stock has a market cap of $763.14 million, a price-to-earnings ratio of -0.48 and a beta of 2.00. The firm’s 50-day moving average is $7.32 and its 200 day moving average is $10.23. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.81 and a quick ratio of 1.72.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.